Letermovir

Letermovir is an antiviral medication used to prevent cytomegalovirus (CMV) infection and disease in people who have received an organ transplant. It works by blocking certain viral enzymes needed for the virus to replicate, stopping the virus from spreading. It is usually taken once daily, starting one month before the transplant and continuing for up to six months afterward. Common side effects include nausea, diarrhea, and headache.

Letermovir is a relatively new prescription medication used to help prevent a specific viral infection in certain situations. Here's a breakdown of its key aspects:

Function: Letermovir belongs to a class of drugs called cytomegalovirus (CMV) inhibitors. CMV is a common herpesvirus that usually doesn't cause problems in healthy individuals. However, in people with weakened immune systems, CMV infection can be serious. Letermovir works by blocking the replication of CMV virus, preventing it from multiplying and causing harm.

Applications: Letermovir is approved for use in adult stem cell transplant recipients to help prevent CMV infection. Stem cell transplant procedures can weaken the immune system, making recipients susceptible to opportunistic infections like CMV. Letermovir is typically used along with other medications to provide additional protection against CMV.

Benefits:

  • Reduces CMV infection risk: Studies show that Letermovir can significantly reduce the risk of developing CMV infection after stem cell transplant compared to placebo (inactive substance).
  • CMV can cause serious complications: CMV infection in transplant recipients can lead to serious health problems like pneumonia, colitis (inflammation of the inner lining of the colon), and retinitis (an eye infection that can threaten vision). Preventing CMV infection helps avoid these potential complications.

Important Considerations:

  • Prevention, not treatment: Letermovir is used to prevent CMV infection, not to treat an existing CMV infection.
  • Not a cure: It doesn't eliminate the CMV virus from the body but helps prevent it from replicating and causing illness.
  • Potential side effects: These can include nausea, headache, diarrhea, and fever.
  • Possible interactions: Letermovir can interact with other medications, so it's crucial to disclose all medications you take to your doctor.
     
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AX Other antivirals
External Links